Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Plasma cell 2Other neoplasm 1Lymphoid 1

Conditions

Leukemia 10Leukemia, Lymphocytic, Chronic, B-Cell 9Congenital Abnormalities 8Leukemia, Myeloid, Acute 7Breast Neoplasms 7Multiple Myeloma 6Lymphoma, Mantle-Cell 6Waldenstrom Macroglobulinemia 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Myeloproliferative Disorders 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Follicular 5Lymphoma, B-Cell, Marginal Zone 5Colorectal Neoplasms 5Colonic Neoplasms 5Burkitt Lymphoma 5Myelodysplastic Syndromes 4Lymphoma, Non-Hodgkin 4Lymphoma, Large-Cell, Immunoblastic 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Myeloid, Chronic-Phase 4Squamous Cell Carcinoma of Head and Neck 3Sezary Syndrome 3Rectal Neoplasms 3Mycosis Fungoides 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, Extranodal NK-T-Cell 3Lymphoma 3Leukemia, Myeloid, Accelerated Phase 3Hodgkin Disease 3

Interventions

Cyclophosphamide 62Dexamethasone 60Melphalan 54Peripheral Blood Stem Cell Transplantation 49Bortezomib 40Busulfan 39fludarabine phosphate 34Filgrastim 32Lenalidomide 30Thalidomide 27Tacrolimus 25Antilymphocyte Serum 23Radiotherapy 22Mycophenolic Acid 17Methotrexate 17Prednisone 15Etoposide 15sargramostim 14Cyclosporine 14fludarabine 12Methylprednisolone 11Granulocyte Colony-Stimulating Factor 11Calcium Dobesilate 11Whole-Body Irradiation 10Doxorubicin 9Carmustine 9pomalidomide 8Vincristine 8Interferon-alpha 8Cord Blood Stem Cell Transplantation 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Neoplasms, Plasma Cell × In Situ Hybridization, Fluorescence × Clear all
NCT00792142 2021-08-19

Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma

City of Hope Medical Center

Phase 2 Completed
45 enrolled 8 charts
Plasma cell

Multiple Myeloma, Neurotoxicity Syndromes, Neoplasms, Plasma Cell

NCT00898066 2015-03-06

S0334 Analyzing Chromosomes in Patients With Newly Diagnosed Multiple Myeloma or Other Blood Disease

SWOG Cancer Research Network

Completed
37 enrolled
LymphoidOther neoplasmPlasma cell

Immunoglobulin Light-chain Amyloidosis, Lymphoma, Waldenstrom Macroglobulinemia, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Precancerous Conditions, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡